ARCTURUS THERAPEUTICS HOLDINGS INC. Proceeds from Maturities, Prepayments and Calls of Short-term Investments
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) reported Proceeds from Maturities, Prepayments and Calls of Short-term Investments of $30.21 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments · last filed 2021-03-01
- ARCTURUS THERAPEUTICS HOLDINGS INC. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2018-12-31 was -$5.00K.
- ARCTURUS THERAPEUTICS HOLDINGS INC. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2018-09-30 was $7.96M.
- ARCTURUS THERAPEUTICS HOLDINGS INC. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2018 was $30.21M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 3 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 6 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 9 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $7.95M derived: sum of 2 quarters · filed 2021-03-01 | $30.21M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $7.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $30.21M 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $22.25M 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |